NCT06614062View on ClinicalTrials.gov

Clinical Study of 18F-FAPI-RGD in Ovarian Cancer

CompletedOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions

Observational

Trial Locations (1)

610072

Departments of Nuclear Medicine, Chengdu

All Listed Sponsors

lead

Sichuan Provincial People's Hospital

OTHER

NCT06614062 - Clinical Study of 18F-FAPI-RGD in Ovarian Cancer | Biotech Hunter | Biotech Hunter